DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹17,717 Cr |
| Mar2024 | ₹15,937 Cr |
| Mar2023 | ₹14,863 Cr |
| Mar2022 | ₹14,619 Cr |
| Mar2021 | ₹11,387 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17,717 Cr | 11.17 | |
| Mar2024 | ₹15,937 Cr | 7.23 | |
| Mar2023 | ₹14,863 Cr | 1.67 | |
| Mar2022 | ₹14,619 Cr | 28.39 | |
| Mar2021 | ₹11,387 Cr | - | |
Compare Total Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹171,786.5 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
| MANKIND PHARMA | ₹94,121.6 Cr | 12.5% | 8.5% | -8.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2.8% |
7.2% |
7.1% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses